Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.

Annals of the rheumatic diseases·2026
Same author

Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.

Rheumatology and therapy·2026
Same author

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.

Rheumatology (Oxford, England)·2026
Same author

Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritis.

Nature reviews. Rheumatology·2026
Same author

Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study.

Rheumatology and therapy·2026

Related Experiment Video

Updated: May 12, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
10:07

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Published on: June 23, 2013

Proteinase-activated receptor-2 modulates human macrophage differentiation and effector function.

Rachael Steven1, Anne Crilly, John C Lockhart

  • 11Centre for Musculoskeletal Science, School of Science, University of the West of Scotland, Paisley, UK.

Innate Immunity
|April 23, 2013
PubMed
Summary

Proteinase-activated receptor-2 (PAR-2) influences human macrophage subsets, regulating cytokine production and cell morphology. PAR-2 activation during maturation alters M1 and M2 macrophage phenotypes, impacting immune responses.

Keywords:
Macrophage subsetsproteinase activated receptor-2

More Related Videos

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
06:38

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on: August 2, 2021

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
08:37

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

Related Experiment Videos

Last Updated: May 12, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
10:07

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Published on: June 23, 2013

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
06:38

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on: August 2, 2021

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
08:37

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • Proteinase-activated receptor-2 (PAR-2) is implicated in immune regulation.
  • The specific role of PAR-2 in human macrophage subset development and function remains unclear.

Purpose of the Study:

  • To investigate PAR-2 expression and activation in human granulocyte-macrophage colony-stimulating factor (GM-CSF)-derived M1 and macrophage colony-stimulating factor (M-CSF)-derived M2 macrophages.
  • To determine the effects of PAR-2 activation on macrophage phenotype, cytokine secretion, and morphology.

Main Methods:

  • Human monocytes were differentiated into M1 and M2 macrophages.
  • PAR-2 activation was induced using the peptide SLIGKV.
  • PAR-2 expression, HLA-DR levels, cell morphology, and cytokine secretion (TNF-α, IL-10) were analyzed.

Main Results:

  • SLIGKV increased PAR-2 expression and regulated TNF-α and IL-10 secretion in both M1 and M2 macrophages, similar to LPS.
  • PAR-2 activation increased HLA-DR on M1 cells.
  • PAR-2 activation during M1 or M2 maturation altered cell morphology and skewed cytokine secretion profiles, impacting TNF-α and IL-10 release.

Conclusions:

  • PAR-2 activation directly influences macrophage subset surface marker expression and cytokine production.
  • PAR-2 plays a complex role in macrophage biology, affecting both mature cell function and differentiation processes.
  • These findings suggest implications for diseases involving proteinase-rich environments and macrophage-driven immune responses.